TIZANIDINE VERSUS BACLOFEN IN THE TREATMENT OF SPASTICITY IN PATIENTS WITH MULTIPLE-SCLEROSIS

被引：54

作者：

BASS, B

WEINSHENKER, B

RICE, GPA

NOSEWORTHY, JH

CAMERON, MGP

HADER, W

BOUCHARD, S

EBERS, GC

机构：

来源：

关键词：

D O I：

10.1017/S0317167100027104

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：15 / 19

页数：5

共 13 条

[1] COWARD DM, 1981, TRIANGLE, V20, P151
[2] ELECTROPHYSIOLOGICAL ANALYSIS OF THE MODE OF ACTION OF MUSCLE-RELAXANTS IN SPASTICITY
DELWAIDE, PJ
[J]. ANNALS OF NEUROLOGY, 1985, 17 (01) : 90 - 95
[3] DOUBLE-BLIND COMPARISON OF SINGLE DOSES OF DS103-282, BACLOFEN AND PLACEBO FOR SUPPRESSION OF SPASTICITY
HASSAN, N
MCLELLAN, DL
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1980, 43 (12) : 1132 - 1136
[4] KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[5] PEDERSEN E, 1965, ACTA NEUROL SCAND, VS 41, P557
[6] NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS
POSER, CM
PATY, DW
SCHEINBERG, L
MCDONALD, WI
DAVIS, FA
EBERS, GC
JOHNSON, KP
SIBLEY, WA
SILBERBERG, DH
TOURTELLOTTE, WW
[J]. ANNALS OF NEUROLOGY, 1983, 13 (03) : 227 - 231
[7] RINGWALD E, 1977, NERVENARZT, V48, P355
[8] RINNE UK, 1980, CURR THER RES CLIN E, V28, P827
[9] BACLOFEN, A NEW ANTI-SPASTIC DRUG - CONTROLLED MULTICENTER TRIAL IN PATIENTS WITH MULTIPLE-SCLEROSIS
SACHAIS, BA
LOGUE, JN
CAREY, MS
[J]. ARCHIVES OF NEUROLOGY, 1977, 34 (07) : 422 - 428
[10] Siegel S., 1956, NONPARAMETRIC STAT B